関連する実験動画
Updated: Sep 8, 2025

07:13
Orienteering as a Tool for Cognitive Research: An Implementation Guide
Published on: November 29, 2024
894
神経認知障害患者の認知機能に対する身体活動の効果: 体系的なレビュー
Théodore Decaix1, Claire Bonnin2, Karl Götze3
1Geriatrics Department, Fernand Widal Lariboisière University Hospital, GHU APHP.Nord, 75010 Paris, France; Paris-Cité University, Inserm U1144, Paris, France.
The Journal of frailty & aging
|September 5, 2025
まとめ
アルツハイマー病やパーキンソン病のような 神経退行性疾患の認知機能に 適した身体活動が有益であることが示されています これらの効果を最大化するために 個別化された運動プログラムが不可欠です
科学分野:
- 神経科学
- ゲロントロジー
- 運動 生理学
背景:
- 神経認知障害は,特に高齢者の機能能力を著しく低下させる.
- 身体活動は神経変性疾患の認知能力を高める 有望な非薬学的アプローチです
- 多様な神経認知症に 合わせた介入が必要なのです
研究 の 目的:
- アルツハイマー病,血管性認知障害,パーキンソン病,ルイ体の認知症の患者の認知機能に対する身体活動の影響を検討する.
- 方法論的厳密さ,参加者の特徴,運動の種類,関連する研究の認知成果を評価する.
- 神経認知障害の管理のための最適な身体活動戦略を特定する.
主な方法:
- 身体活動と神経認知障害に関する21の研究の文献レビュー.
- 研究設計,参加者の人口統計,運動介入 (エアロビック,抵抗など) の分析 認知能力の評価について
- 報告された認知および機能的結果の評価
主要な成果:
- 21件のうち14件で,運動が認知機能,特に有酸素活動に有益な効果があると報告された.
- 効果の大きさは控えめで,結果は様々であった.
- 提案されたメカニズムには,アミロイド/タウ負荷の減少,グルコース代謝の改善,アルツハイマー病におけるBDNFの増加,パーキンソン病におけるドーパミン経路の調節が含まれています.
結論:
- 身体活動は神経変性疾患における 認知の健康を支える重要な非薬学的介入です
- 特定の条件に合わせた個別化された運動プログラムは,研究の可変性のために必要である.
- 長期的な効果,最適な方法,標準化された評価基準を決定するためにさらなる研究が必要である.
関連する概念動画
Cognitive Development During Adulthood
250
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
250
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
Exercise and Cardiac Output
1.3K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
1.3K
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Parkinson's Disease: Treatment
375
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
375

